LYTLE PAUL J bought ACTU
April 1, 2026 · Form 4 insider transaction
LYTLE PAUL J bought 105,000 shares of Actuate Therapeutics, Inc. Common stock at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
105,000
Price
$0.00
Total value
N/A
InsiderLYTLE PAUL J
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 1, 2026
Shares owned after105,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options will vest as to 25% on April 1, 2027 with the remaining 75% vesting in equal monthly installments during the 36 months following the first anniversary of the grant date.